Drugdiscovery >> Clinical Trials >> News
6040
Views
Sofosbuvir effective in Phase II clinical trial for  hepatitis C - drugdiscovery.com
Sofosbuvir effective in Phase II clinical trial for hepatitis C - drugdiscovery.com


Gilead's experimental drug sofosbuvir in combination with ribavirin showed to be effective and safe interferon-free therapy for even some of the toughest hepatitis C cases.
Read More >>


Tags: sofosbuvir, hepatitis C, interferon-free therapy, ribavirin, clinical trial, Gilead - August 28, 2013
Related Articles
2756
Views
Interferon-free hepatitis coctail of AbbVie enters Phase III Interferon-free hepatitis coctail of AbbVie enters Phase III
The new drug of AbbVie has entered clinical trial phase II. It cures hepatitis C, and provides a ribavirin-free, all-oral treatment without interferon. Read More >>

Tags: interferon, hepatitis C, clinical trial, Phase III

5320
Views
Lampalizumab  effective in Phase II clinical trial for macular degeneration Lampalizumab effective in Phase II clinical trial for macular degeneration
Roche’s new drug for age-related macular degeneration, lampalizumab, showed effective in slowing the progression of AMD in patients with advanced disease, shrinking the area of geographic atrophy by Read More >>

Tags: macular degeneration, age related, AMD, lampalizumab, clinical trial, Roche, new treatnment

4761
Views
Teplizumab effective in phase 2 Teplizumab effective in phase 2
Teplizumab is an experimental drug designed to block the advance of type 1 diabetes in its earliest stages. It showed success in phase II clinical trial in patients who still had moderately healthy Read More >>

Tags: Teplizumab,experimental drug, clinical trial, type 1 diabetes, insulin, immunotherapy

6853
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

8039
Views
Medivir’s bone drug successful in Phase 1 clinical trial Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased car Read More >>

Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial

7128
Views
Special Protocol Assessment  for a Phase 3 clinical trial of antibiotic plazomicin Special Protocol Assessment for a Phase 3 clinical trial of antibiotic plazomicin
Plazomicin is a next-generation aminoglycoside antibiotic engineered by Achaogen. It has potent bactericidal activity against important gram-negative pathogens, including carbapenem-resistant Enteroba Read More >>

Tags: plazomicin, antibiotic, aminoglycoside antibiotic, next generation, Achaogen, gram-negative, CRE, clinical trial, multi-drug resistant, MDR, bacterial infections

5560
Views
Edison Pharmaceuticals announces Phase 2 trial of EPI-743 Edison Pharmaceuticals announces Phase 2 trial of EPI-743
A trial is a double-blind, placebo-controlled crossover study of EPI-743 in patients with defined or undefined genetic diagnoses that feature cellular oxidation/reduction or energy production defects. Read More >>

Tags: Edison, clinical trial, EPI-743, disorders of energy utilization, oxidation-reduction

6930
Views
A global Phase 3 clinical trial for Alzheimer’s disease to be lounched A global Phase 3 clinical trial for Alzheimer’s disease to be lounched
Takeda and Zinfandel have announced the initiation of TOMMORROW Phase 3 clinical trial which will investigate a genetic-based biomarker risk assignment algorithm for the predicition of the risk of mil Read More >>

Tags: clinical trial, global, Alzheimer’s disease, Takeda, Zinfandel, risk assignment algorithm, cognitive impairment risk, pioglitazone, investigational drug

13094
Views
PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma
Patrys Limited has released additional clinical data for six end-stage, multi-resistant multiple myeloma patients treated with PAT-SM6. The trial is progressing to its 4th and final patient cohort. Read More >>

Tags: multiple myeloma, clinical trial, PAT-SM6, antibody, Patrys Limited, end stage

7142
Views
Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS
Cytokinetics’ drug Tirasemtiv, a fast skeletal muscle troponin activator, shows safe and tolerable in two prior Phase 2 trials in patients with amyotrophic lateral sclerosis (ALS). The compound is Read More >>

Tags: Tirasemtiv, ALS, clinical trial, skeletal muscle troponin activator, amyotrophic lateral sclerosis, Cytokinetics

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013